Citation Impact
Citing Papers
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance
2014 Standout
Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐ResistantStreptococcus pneumoniae
2002
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Varicella-zoster virus: Infection, control, and prevention
1998
Breakthrough Pneumococcal Bacteremia in Patients Being Treated with Azithromycin and Clarithromycin
2000
Management of Community-Acquired Pneumonia in the Era of Pneumococcal Resistance
2000
Cystic fibrosis
2016 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
The Diagnosis and Management of Acute Otitis Media
2013 Standout
Defining an exacerbation of pulmonary disease in cystic fibrosis*
2001
BTS guidelines for the management of pleural infection in children
2005 Standout
Clinical applications of C-reactive protein in pediatrics
1997 Standout
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study
2003 Standout
Toxic Shock Syndrome in Association with Group-A Streptococcal Infection of a Knee Joint after a Total Knee Arthroplasty. A Case Report*
1998
Bacteremic Pneumonia Due to Multidrug-Resistant Pneumococci in 3 Patients Treated Unsuccessfully with Azithromycin and Successfully with Levofloxacin
2000
Clinical Relevance of Streptococcal Pyrogenic Exotoxins in Streptococcal Toxic Shock-Like Syndrome and Other Severe Invasive Infections
1992
Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Serious Group A β-Hemolytic Streptococcal Infections Complicating Varicella
1994
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
2009
Antimicrobial Therapy for Chronic Osteomyelitis in Adults: Role of the Quinolones
1997
Invasive aspergillosis in patients with liver disease
2010
Systematic Review of Blood Biomarkers in Cystic Fibrosis Pulmonary Exacerbations
2013
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Fatal Group A Streptococcal Meningitis and Toxic Shock-Like Syndrome: Case Report
1994
Natural history of liver fibrosis progression in patients with chronic hepatitis C
1997 Standout
Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media
2001
Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis
2004 Standout
Toxin‐Gene Profile Heterogeneity among Endemic Invasive European Group A Streptococcal Isolates
2003 StandoutNobel
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Treatment of drug-resistant pneumococcal pneumonia
2002
Pathogenesis of Group A Streptococcal Infections
2000 Standout
Antimicrobial Treatment Guidelines for Acute Bacterial Rhinosinusitis
2004
LIVE ATTENUATED VARICELLA VACCINE
1996
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
The usefulness of C-reactive protein levels in the identification of concurrent septic arthritis in children who have acute hematogenous osteomyelitis. A comparison with the usefulness of the erythrocyte sedimentation rate and the white blood-cell count.
1994
Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society
2000
Varicella-zoster virus
1996 Standout
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Summary of notifiable diseases--United States, 2002.
2004 Standout
Whatʼs New in Pediatric Orthopaedics
2004 Standout
Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal
1995
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
2008 Standout
Cost-effectiveness of a Routine Varicella Vaccination Program for US Children
1994
Clinical Practice Guideline (Update): Adult Sinusitis
2015 Standout
Prosthetic Joint Infection
2014 Standout
A CLINICAL PRACTICE GUIDELINE FOR TREATMENT OF SEPTIC ARTHRITIS IN CHILDREN
2003
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
An Epidemiological Investigation of a Sustained High Rate of Pediatric Parapneumonic Empyema: Risk Factors and Microbiological Associations
2002
Clinical practice guideline: Adult sinusitis
2007 Standout
Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 Oral Antimicrobial Agents Based on Pharmacodynamic Parameters: 1997 U.S. Surveillance Study
1999
Works of V. Fred Burry being referenced
Breakthrough Sepsis in Macrolide-Resistant Pneumococcal Infection
1996
Multisystem Group A -Hemolytic Streptococcal Disease in Children
1991
C‐reactive protein in acute pulmonary exacerbations of patients with cystic fibrosis
1995
Complications of varicella requiring hospitalization in previously healthy children
1992
Pyogenic arthritis associated with adjacent osteomyelitis
1992
Disseminated aspergillosis during treatment of hepatic failure
1973
Hepatitis B Virus Vaccine
1989